Skip to main content

Chemoprevention of Experimental Tumorigenesis by Dehydroepiandrosterone and Structural Analogs

  • Chapter
Chemical Carcinogenesis

Abstract

The human adrenal cortex secretes three classes of steroid hormone: glucocorticoid, mineralcorticoid and the so-called adrenal androgens, dehydroepiandrosterone (DHEA) and DHEA-sulfate. The term adrenal androgen is not strictly accurate since DHEA per se is not androgenic and only through metabolism to steroids such as testosterone does it exert such action. DHEA-sulfate is also a principal source of estrogen, through placental metabolism, in the pregnant female1,2. However, in the normal male and female the proportion of sex steroids derived from adrenal DHEA is very small compared to the gonadal contribution, and the significance of the adrenal secretion of DHEA and DHEA-sulfate remains unclear3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. E. E. Baulieu and F. Dray, Conversion of [3H]dehydroisoandrosterone (3 ß-hydroxy-Δ5-androsten-17-one) sulfate to [3H]estrogens in normal pregnant women, J. Clin. Endocrinol. Metab. 23:1298 (1963).

    Article  PubMed  CAS  Google Scholar 

  2. P. K. Siiteri and P. C. MacDonald, The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy, Steroids 2:713 (1963).

    Article  CAS  Google Scholar 

  3. S. Lieberman, Pictorial endocrinology and empirical hormonology, The Sir Henry Dale Lecture for 1986, J. Endocr. 111:519 (1986).

    Article  PubMed  CAS  Google Scholar 

  4. N. Orentriech, J. L. Brind, R. L. Rizer and J. H. Vogelman, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J. Clin. Endocrinol. Metab. 59:551 (1984).

    Article  Google Scholar 

  5. C. Gherondache, L. Romanoff and G. Pincus, Steroid hormones in aging men, in: “Endocrines and Aging”, L. Gitman, ed., Charles Thomas, Springfield, IL (1967).

    Google Scholar 

  6. P. Weidman, S. deMyttenaere-Bursztein, M. Maxwell, and J. deLima, Effect of aging on plasma renin and aldosterone in normal man, Kidney Int. 8:325 (1975).

    Article  Google Scholar 

  7. L. Parker, T. Gral, V. Perrigo and R. Shorosky, Decreased adrenal androgen sensitivity to ACTH during aging, Metabolism 30:601 (1981).

    Article  PubMed  CAS  Google Scholar 

  8. R. D. Bulbrook, J. L. Hayward, C. C. Spicer and B. S. Thomas, Abnormal excretion of urinary steroids by women with early breast cancer Lancet ii:1238 (1962).

    Article  Google Scholar 

  9. R. D. Bulbrook, J. L. Hayward and C. C. Spicer, Relation between urinary androgen and corticoid excretion and subsequent breast cancer, Lancet ii:395 (1971).

    Article  Google Scholar 

  10. A. G. Schwartz, Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone, Cancer Res. 39:1129 (1979).

    PubMed  CAS  Google Scholar 

  11. A. G. Schwartz and R. H. Tannen, Inhibition of 7,12-dimethylbenz(a)anthracene-and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone, Carcinogenesis 2:1335 (1981).

    Article  PubMed  CAS  Google Scholar 

  12. J. W. Nyce, P. N. Magee, G. C. Hard and A. G. Schwartz, Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone, Carcinogenesis 5:57 (1984).

    Article  PubMed  CAS  Google Scholar 

  13. M. A. Moore, W. Thamavit, A. Tsuda, K. Sato, A. Ichihara and N. Ito, Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats, Carcinogenesis 7:311 (1986).

    Article  PubMed  CAS  Google Scholar 

  14. R. Garcea, L. Daino, R. Pascale, S. Frassetto, P. Cozzolino, M. E. Ruggiu and F. Feo, Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis, Toxicol. Path. 15:164 (1987).

    Article  CAS  Google Scholar 

  15. L. L. Pashko, R. J. Rovito, J. R. Williams, E. L. Sobel and A. G. Schwartz, Dehydroepiandrosterone (DHEA) and 3 ß-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz(a)anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice, Carcinogenesis 5:463 (1984).

    Article  PubMed  CAS  Google Scholar 

  16. L. L. Pashko, G. C. Hard, R. J. Rovito, J. R. Williams, E. L. Sobel and A. G. Schwartz, Inhibition of 7,12-dimethylbenz(a)anthraceneinduced skin papillomas and carcinomas by dehydroepiandrosterone and 3 ß-methylandrost-5-en-17-one in mice, Cancer Res. 45:164 (1985).

    PubMed  CAS  Google Scholar 

  17. P. A. Marks and J. Banks, Inhibition of mammalian glucose-6-phosphate dehydrogenase by steroids, Proc. Natl. Acad. Sci. USA 46:447 (1960).

    Article  PubMed  CAS  Google Scholar 

  18. G. W. Oertel and P. Benes, The effects of steroids on glucose-6-phosphate dehydrogenase, J. Steroid Biochem. 3:493 (1972).

    Article  PubMed  CAS  Google Scholar 

  19. A. G. Schwartz and A. Perantoni, Protective effect of dehydroepiandrosterone against aflatoxin B1, and 7,12-dimethylbenz(a)anthraceneinduced cytotoxicity and transformation in cultured cells, Cancer Res. 35:2482 (1975).

    PubMed  CAS  Google Scholar 

  20. J. A. Miller, Carcinogenesis by chemicals: an overview, Cancer Res. 30:559 (1970).

    PubMed  CAS  Google Scholar 

  21. F. Feo, L. Pirisi, R. Pascale, L. Daino, S. Frassetto, R. Garcea and L. Gaspa, Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts, Cancer Res. 44:3419 (1984).

    PubMed  CAS  Google Scholar 

  22. F. Feo, L. Pirisi, R. Pascale, L. Daino, S. Frassetto, S. Zanetti and R. Garcea, 1984, Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in benzo(a)pyrene activation, Toxicol. Path. 11:261 (1984).

    Article  Google Scholar 

  23. L. L. Pashko and A. G. Schwartz, Effect of food restriction, dehydroepiandrosterone, or obesity on the binding of [3H]-7,12-dimethylbenz(a)anthracene to mouse skin DNA, J. Gerontol. 38:8 (1983).

    Article  PubMed  CAS  Google Scholar 

  24. T. S. Argyris, Nature of epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice, Cancer Res. 43:1768 (1983).

    PubMed  CAS  Google Scholar 

  25. V. Kinzel, H. Lochrke, L. Goertler, G. Fürstenberger and F. Marks, Suppression of the first stage of phorbol 12-tetradecanoate-13-acetateeffected tumor promotion in mouse skin by non-toxic inhibition of DNA synthesis, Proc. Natl. Acad. Sci. USA 81:5858 (1984).

    Article  PubMed  CAS  Google Scholar 

  26. L. L. Pashko, A. G. Schwartz, M. Abou-Gharbia and D. Swern, Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids, Carcinogenesis 2:717 (1981).

    Article  PubMed  CAS  Google Scholar 

  27. R. Raineri and H. R. Levy, On the specificity of steroid interaction with mammary gland glucose-6-phosphate dehydrogenase, Biochemistry 9:2233 (1970).

    Article  PubMed  CAS  Google Scholar 

  28. C. W. Castor and B. L. Baker, The local action of adrenocortical steroids on epidermis and connective tissue of the skin, J. Endocrinol. 47:234 (1950).

    Article  CAS  Google Scholar 

  29. H. Green and O. Kehinde, An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion, Cell 5:19 (1975).

    Article  PubMed  CAS  Google Scholar 

  30. G. B. Gordon, J. A. Newitt, L. M. Shantz, D. E. Weng and P. Talalay, Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids, Cancer Res. 46:3389 (1986).

    PubMed  CAS  Google Scholar 

  31. C. R. Dworkin, S. D. Gorman, L. L. Pashko, V. J. Cristofallo and A. G. Schwartz, Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo-and deoxyribonucleosides, Life Sci. 38:1451 (1986).

    Article  PubMed  CAS  Google Scholar 

  32. G. B. Gordon, L. M. Shantz and P. Talalay, Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone, Adv. Enzyme Regulation 26:355 (1987).

    Article  CAS  Google Scholar 

  33. F. Feo, R. Garcea, L. Daino, S. Frassetto, P. Cozzolino, M. E. Ruggiu, M. G. Vannini, R. Pascale, L. Lenzerini, M. M. Simile and M. Puddu, Inhibition of hepatocarcinogenesis promotion by dehydroepiandrosterone and its reversal by ribo-and deoxyribonucleosides, Fourth Sardinian International Meeting: Models and Mechanisms in Chemical Carcinogenesis, abstract, (1987).

    Google Scholar 

  34. B. M. Babior, The enzymatic basis for 0 2 production by human neutrophils, Can. J. Physiol. Pharmacol. 60:1353 (1982).

    Article  PubMed  CAS  Google Scholar 

  35. I. Emerit and P. Cerutti, Clastogenic action of tumor promoter phorbol-12-myristate-13-acetate in mixed human leukocyte cultures, Carcinogenesis 4:1313 (1983).

    Article  PubMed  CAS  Google Scholar 

  36. A. W. Hsie, L. Recio, D. S. Katz, C. Q. Lee, M. Wagner and R. L. Schenley, Evidence for reactive oxygen species inducing mutations in mammalian cells, Proc. Natl. Acad. Sci. USA 83:9616 (1986).

    Article  PubMed  CAS  Google Scholar 

  37. C. Borek and W. Troll, Modifiers of free radicals inhibit in vitro the oncogenic actions of X-rays, bleomycin and the tumor promoter 12-0-tetradecanoylphorbol-13-acetate, Proc. Natl. Acad. Sci. USA 80:1304 (1983).

    Article  PubMed  CAS  Google Scholar 

  38. T. W. Kensler, D. M. Bush and W. J. Kozumbo, Inhibition of tumor promotion by a biomimetic Superoxide dismutase, Science 221:75 (1983).

    Article  PubMed  CAS  Google Scholar 

  39. B. D. Goldstein, G. Witz, M. Amoruso, D. S. Stone, and W. Troll, Stimulation of human polymorphonuclear leukocyte Superoxide anion radical production by tumor promoters, Cancer Lett. 11:257 (1981).

    Article  PubMed  CAS  Google Scholar 

  40. J. M. Whitcomb and A. G. Schwartz, Dehydroepiandrosterone and 16α-Br-epiandrosterone inhibit 12-0-tetradecanoylphorbol-13-acetate stimulation of Superoxide radical production by human polymorphonuclear leukocytes, Carcinogenesis 6:333 (1985).

    Article  PubMed  CAS  Google Scholar 

  41. A. G. Schwartz and L. L. Pashko, Food restriction inhibits [3H] 7, 12-di-methylbenz(a)anthracene binding to mouse skin DNA and tetradecanoylphorbol-13-acetate stimulation of epidermal [3H]thymidine incorporation, Anticancer Res. 6:1279 (1986).

    PubMed  CAS  Google Scholar 

  42. S. Dessi, B. Batetta, D. Pulixi, A. Carrucciu, M. Armeni, M. F. Mulas and P. Pani, Modifying influence of fasting on DNA synthesis, cholesterol metabolism and HMP shunt enzymes in liver hyperplasia induced by lead nitrate, Fourth Sardinian International Meeting: Models and Mechanisms in Chemical Carcinogenesis, abstract, (1987).

    Google Scholar 

  43. E. Aizu, T. Nakadate, S. Yamamoto and R. Kato, Inhibition of 12-0-tetradecanoylphorbol-13-acetate mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects, Carcinogenesis 7:1809 (1986).

    Article  PubMed  CAS  Google Scholar 

  44. P. A. Craven, J. Pfanstiel and F. R. DeRubertis, Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids, J. Clin. Invest. 79:532 (1987).

    Article  PubMed  CAS  Google Scholar 

  45. Y. S. Bakhle, Synthesis and catabolism of cyclo-oxygenase product, Brit. Med. Bull. 39:214 (1983).

    PubMed  CAS  Google Scholar 

  46. G. W. Taylor and H. R. Morris, Lipoxygenase pathways, Brit. Med. Bull. 39:219 (1983).

    PubMed  CAS  Google Scholar 

  47. S. M. Fischer and L. M. Adams, Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism, Cancer Res. 45:3130 (1985).

    PubMed  CAS  Google Scholar 

  48. G. Fürstenberger and F. Marks, Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis, Biochem. Biophys. Res. Commun. 84:1103 (1978).

    Article  PubMed  Google Scholar 

  49. L. A. Hastings, L. L. Pashko, M. L. Lewbart and A. G. Schwartz, Dehydroepiandrosterone and two structural analogs inhibit tetradecanoylphorbol-13-acetate stimulation of prostaglandin E2 content in mouse skin, submitted.

    Google Scholar 

  50. M. Nagao, T. Ishibashi, T. Okayasu and Y. Imai, Possible involvement of NADPH-cytochrome P-450 reductase and cytochrome b5 on ß-ketostearoyl-CoA reduction in microsomal fatty acid chain elongation supported by NADPH, FEBS Letters 155:11 (1983).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schwartz, A.G., Pashko, L.L., Hastings, L.A., Whitcomb, J.H., Lewbart, M.L. (1988). Chemoprevention of Experimental Tumorigenesis by Dehydroepiandrosterone and Structural Analogs. In: Feo, F., Pani, P., Columbano, A., Garcea, R. (eds) Chemical Carcinogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9640-7_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9640-7_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9642-1

  • Online ISBN: 978-1-4757-9640-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics